Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131 I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma
Category
Published on
Type
journal-article
Author
Kevin Campbell and Erin E. Karski and Aleksandra Olow and David A. Edmondson and Ayano C. Kohlgruber and Matthew Coleman and Daphne A. Haas-Kogan and Katherine K. Matthay and Steven G. DuBois
Citation
Campbell, K. et al., 2017. Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131 I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma. International Journal of Radiation Oncology*Biology*Physics, 99(2), pp.468–475. Available at: http://dx.doi.org/10.1016/j.ijrobp.2017.05.008.